Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jeremy Barben"'
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
Autor:
Mathieu Blot, Jean-Baptiste Bour, Jean Pierre Quenot, Abderrahmane Bourredjem, Maxime Nguyen, Julien Guy, Serge Monier, Marjolaine Georges, Audrey Large, Auguste Dargent, Alexandre Guilhem, Suzanne Mouries-Martin, Jeremy Barben, Belaid Bouhemad, Pierre-Emmanuel Charles, Pascal Chavanet, Christine Binquet, Lionel Piroth, for the LYMPHONIE study group
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-14 (2020)
Abstract Background Although immune modulation is a promising therapeutic avenue in coronavirus disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has peculiar characteristics and outcomes, suggesting a unique immunopatho
Externí odkaz:
https://doaj.org/article/c3eeda29cace4aca802f2b4fe851cbe9
Autor:
Mathieu Blot, Jean-Baptiste Bour, Jean Pierre Quenot, Abderrahmane Bourredjem, Maxime Nguyen, Julien Guy, Serge Monier, Marjolaine Georges, Audrey Large, Auguste Dargent, Alexandre Guilhem, Suzanne Mouries-Martin, Jeremy Barben, Belaid Bouhemad, Pierre‑Emmanuel Charles, Pascal Chavanet, Christine Binquet, Lionel Piroth, for the LYMPHONIE Study Group
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-2 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/727031d929fa456db66b470ab4e28209
Autor:
Pauline Walzer, Clémentine Estève, Jeremy Barben, Didier Menu, Christine Cuenot, Patrick Manckoundia, Alain Putot
Publikováno v:
Vaccines, Vol 8, Iss 3, p 356 (2020)
Influenza remains a major cause of illness and death in geriatric populations. While the influenza vaccine has successfully reduced morbidity and mortality, its effectiveness is suspected to decrease with age. The aim of this study was to assess the
Externí odkaz:
https://doaj.org/article/1cdd4e2ab2b94bfebf8af6c85f6905eb
Autor:
Alain Putot, Karine Astruc, Jeremy Barben, Anca Maria Mihai, Valentine Nuss, Julien Bador, Sophie Putot, Mélanie Dipanda, Caroline Laborde, Jeremie Vovelle, Sofia Da Silva, Emmanuel Mazen, Ludwig Serge Aho Glélé, Patrick Manckoundia
Publikováno v:
Antibiotics, Vol 9, Iss 6, p 303 (2020)
In 2015, a major increase in incident hospital-onset Clostridioides difficile infections (HO-CDI) in a geriatric university hospital led to the implementation of a diagnosis-centered antibiotic stewardship program (ASP). We aimed to evaluate the impa
Externí odkaz:
https://doaj.org/article/e9355c8dc28f4f63babccf5448329af2
Autor:
Patrick Manckoundia, Patrick Ray, Valérie Quipourt, Laurence Vaillard, Mélanie Dipanda, Fabrice Larosa, Didier Menu, Hélène Sordet Guepet, Alain Putot, Jeremy Barben
Publikováno v:
Soins Gérontologie. 28:42-45
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
Autor:
Lionel Piroth, Jean-Baptiste Bour, Julien Guy, P. Chavanet, Audrey Large, Auguste Dargent, Belaid Bouhemad, Jean Pierre Quenot, Jeremy Barben, Pierre-Emmanuel Charles, Maxime Nguyen, Christine Binquet, Mathieu Blot, Serge Monier, Abderrahmane Bourredjem, Alexandre Guilhem, Marjolaine Georges, Suzanne Mouries-Martin
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-14 (2020)
Journal of Translational Medicine
Journal of Translational Medicine
Background Although immune modulation is a promising therapeutic avenue in coronavirus disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has peculiar characteristics and outcomes, suggesting a unique immunopathogenesis.
Autor:
Jérémie, Vovelle, Jeremy, Barben, Agnés, Camus, Anca-Maria, Mihai, Mélanie, Dipanda, Valentine, Nuss, Caroline, Laborde, Sophie, Putot, Alain, Putot, Patrick, Manckoundia
Publikováno v:
Geriatrie et psychologie neuropsychiatrie du vieillissement.
Due to the diversity of the elderly population and medical practices, the decision to transfer elderly patients to an intensive care unit is complex. This study aimed to identify the criteria used to take an advance decision to limit transfer to an i
Autor:
Abderrahmane Bourredjem, Alexandre Guilhem, Jean-Baptiste Bour, Marjolaine Georges, Lionel Piroth, Pierre-Emmanuel Charles, P. Chavanet, Jean Pierre Quenot, Jeremy Barben, Audrey Large, Belaid Bouhemad, Serge Monier, Christine Binquet, Maxime Nguyen, Mathieu Blot, Julien Guy, Auguste Dargent, Suzanne Mouries-Martin
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-2 (2021)
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-2 (2021)
Although immune modulation is a promising therapeutic avenue in coronavirus disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has peculiar characteristics and outcomes, suggesting a unique immunopathogenesis.Thirty-six i
Autor:
Vincent Dubée, Pierre-Marie Roy, Bruno Vielle, Elsa Parot-Schinkel, Odile Blanchet, Astrid Darsonval, Caroline Lefeuvre, Chadi Abbara, Sophie Boucher, Edouard Devaud, Olivier Robineau, Patrick Rispal, Thomas Guimard, Emma d’Anglejean, Sylvain Diamantis, Marc-Antoine Custaud, Isabelle Pellier, Alain Mercat, Antoine Brangier, Philippe Codron, Jean Michel Lemée, Virginie Pichon, Robin Dhersin, Geoffrey Urbanski, Christian Lavigne, Roxane Courtois, Hélène Danielou, Jonathan Lebreton, Rémi Vatan, Nicolas Crochette, Jean-Baptiste Lainé, Lucia Perez, Sophie Blanchi, Hikombo Hitoto, Louis Bernard, François Maillot, Sylvain Marchand Adam, Jean-Philippe Talarmin, Emeline Gaigneux, Pauline Motte-Vincent, Marine Morrier, Dominique Merrien, Yves Bleher, Maxime Flori, Amélie Ducet-Boiffard, Orane Colin, Ronan Février, Pauline Thill, Macha Tetart, François Demaeght, Barthelemy Lafond-Desmurs, Maxime Pradier, Agnes Meybeck, Marjorie Picaud, Thierry Prazuck, Guillaume Chapelet, Agnès Rouaud, Paul Le Turnier, Simon Sunder, Aurélien Lorleac'h, Christophe Dollon, Antoine Jacquet, Francois Le Vely, Pierre Gazeau, Séverine Ansart, Hélène Roger, François Laterza, Rodolphe Buzelé, Fella Tahmi, Raphael Lepeule, Karine Lacombe, Bénédicte Lefebvre, Thomas Célarier, Amandine Gagneux-Brunon, Elisabeth Botelho-Nevers, Marc Bernard, Camille Garnier, Morgane Mourguet, Gregory Pugnet, Sara Vienne-Noyes, Guillaume Martin-Blondel, Pierre Delobel, Gaspard Grouteau, Alexa Debard, Laurent Guilleminault, Pauline Arias, Catherine Chakvetadze, Clara Flateau, Aude Kopp, Alain Putot, Jeremy Barben, Suzanne Mouries Martin, Valentine Nuss, Lionel Piroth, Yann-Erick Claessens, Veronique Hentgen, Martin Martinot, Maxime Bach-Bunner, Thomas Bonijoly, Simon Gravier, Jean-Marc Michel, Mathilde Andreu, Mélanie Roriz, Aurélie Baldolli, Julia Brochard, Olivier Grossi, Samuel Pineau, Josselin Brisset, Edouard Desvaux, Guillaume Gondran, Jean-François Faucher, Paul-Antoine Quesnel, Holy Bezanahary, Clément Danthu, Blandine Gutierrez, Kim Ly, Yannick Simonneau, Anne Cypierre, Pauline Pinet, Hélène Durox, Sophie Ducroix-Roubertou, Claire Genet, Guillaume Beraud, Gwenael Le Moal, Blandine Rammaert, Jean-Philippe Lanoix, Claire Andrejak, Cédric Joseph, Sandrine Soriot-Thomas, Robin Dhote, Sébastien Abad, Ruben Benainous, Jean-François Boitiaux, Guillaume Briend, Celine Gonfroy, Stanislas Harent, Aurore Lagrange, Alina Tone, Laura Wayenberg, Sophie Desoutter, Nicolas Ettahar, Thomas Gey, Vincent Leroy, Sacha Gaillard, Andrea Toma, Amaury Broussier, Sandrine Etienne, Yann Spivac, Benoit Martha, Nathalie Roch, Pierre Diaz, Danièle N’guyen Baranoff, Stanislas Rebaudet, François Jourda, Valérie Zeller, Boris Bienvenu, Arnaud Boyer, Marie Briet, Bertrand Guidet, Patrick Mismetti, Eric Vicaut, Olivier Sanchez, Philippe Girard, Antoine Elias, Francis Couturaud, Béatrice Gable, Sybille Lazareff, Loïc Carballido, Catherine Hue, Jean-Marie Chrétien, Adrien Goraguer, Lucie van Eeckhoutte
Publikováno v:
Clinical Microbiology and Infection
Clinical Microbiology and Infection, 2020, 27 (8), pp.1124-1130. ⟨10.1016/j.cmi.2021.03.005⟩
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2020, 27, pp.1124-1130. ⟨10.1016/j.cmi.2021.03.005⟩
Clinical Microbiology and Infection, 2020, 27 (8), pp.1124-1130. ⟨10.1016/j.cmi.2021.03.005⟩
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2020, 27, pp.1124-1130. ⟨10.1016/j.cmi.2021.03.005⟩
Objectives To determine whether hydroxychloroquine decreases the risk of adverse outcome in patients with mild to moderate coronavirus disease 2019 (COVID-19) at high risk of worsening. Methods We conducted a multicentre randomized double-blind place
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45269d482df3c9b8818da066dfc10e2a
https://www.hal.inserm.fr/inserm-03339719/document
https://www.hal.inserm.fr/inserm-03339719/document
Publikováno v:
Current Oncology, Vol 28, Iss 1, Pp 961-964 (2021)
An 82-year-old woman treated for advanced lung cancer with gefitinb was admitted to the emergency unit complaining of dyspnea. Chest computed tomography found abnormalities classified as possible diffuse COVID-19 pneumonia. RT-PCR for Sars-Cov-2 was
Externí odkaz:
https://doaj.org/article/ecfe2cbe47b648e1b35c5c62208209dc